Interventional Pulmonology Course is organized by University of Texas MD Anderson Cancer Center and will be held during Feb 22 - 23, 2018 at Onstead Auditorium - University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
The target audience for this medical event is board-eligible/certified pulmonologists, thoracic surgeons, and trainees in pulmonary, critical care medicine, and thoracic surgery that have an interest in interventional pulmonology. This CME Conference has been approved for a maximum of 13.75 AMA PRA Category 1 Credits.
Conference Description :
The activity is designed to review the current concepts and recent advances in interventional pulmonology as it pertains to the cancer patient, and to introduce new technologic advances that are poised to revolutionize the diagnosis, staging, and management of lung cancer.
Malignancies involving the lungs continue to provide a significant challenge to chest physicians. With the exponential increase in technology, several minimally-invasive diagnostic and therapeutic strategies are becoming feasible. As the largest cancer center in the world, MD Anderson is able to offer a depth and breadth of clinical experience and training that few can match. With a distinguished faculty made up of the world’s top experts, this course is designed to provide the participant with a state-of-the-art review of the principles and practice of interventional pulmonology in patients with thoracic malignancies.
This activity will be offer various educational formats. Twelve didactic lectures will be available online. The lectures will address screening, staging, airway management, anesthesia techniques and Endobronchial Ultrasound. This information will prepare participants for the live activity, where these content areas will be discussed during didactic and case presentations.
In addition to attending interactive didactic sessions, participants will also receive extensive practical instruction in selected techniques utilizing in vivo animal models. Instruction group size is limited in order to maximize interaction and individual “hot zone” time. Additional instruction can be individualized for those wishing to emphasize particular techniques. Endobronchial Ultrasound techniques will be particularly stressed and participants should be able to acquire the cognitive and technical skills to safely perform Endobronchial Ultrasound guided transbronchial needle biopsies upon course completion.
Conference Objectives are :
• Utilize appropriate lung cancer screening techniques according to national guidelines and standards (knowledge, competence, performance);
• Assimilate the therapeutic options for management of airway tumors (knowledge, competence);
• Interpret the available evidence for adjunctive therapies in the palliative and curative management of lung cancer (knowledge, competence);
• Utilize the principles of evidence based medicine in evaluating new technologies (knowledge, competence);
• Demonstrate the ability to perform Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration on a porcine model and to perform other aspects of cytological diagnosis (knowledge, competence, performance, patient outcomes);
• Perform endobronchial stenting on a porcine model (knowledge, competence, performance, patient outcomes);
• Incorporate evidence based best practices for the management of recurrent malignant pleural effusions (knowledge, competence, performance)
Additional details will be posted as soon as they are available.
|Registration Type||End Date||Price|
|Physician (Full Course) Fee||21 Feb,2018||USD 2350.00|
|Physician (Live Didactic) Fee||21 Feb,2018||USD 1200.00|